| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 09/28/2006 | US20060217364 Beta-lactamyl vasopressin V1a antagonists |
| 09/28/2006 | US20060217358 Use of derivatives of cholest-4-en-3-one as medicaments, pharmaceutical compositions containing same, novel derivatives and preparation method thereof |
| 09/28/2006 | US20060217349 Having antiinflammatory, anti-pyretic and anti-diarrheal properties |
| 09/28/2006 | US20060217348 Pyrazolo[1,5-a] pyridines and medicines containing the same |
| 09/28/2006 | US20060217314 Feline hepatocyte growth factor |
| 09/28/2006 | US20060217295 Neuroprotective macrocyclic compounds and methods for their use |
| 09/28/2006 | US20060216799 Treatment of CNS disorders with trans 4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-1-napthalenamine and its formamide |
| 09/28/2006 | US20060216758 Antibodies to transferrin receptor-like proteins |
| 09/28/2006 | US20060216705 Transcription activation complex and utilization thereof |
| 09/28/2006 | US20060216349 Ibuprofen composition |
| 09/28/2006 | US20060216340 drug delivery at least two-day additional dosing interval; allows for reduced plasma concentrations over a prolonged time period while still providing effective pain management; transdermal delivery system maximizes the dosage interval |
| 09/28/2006 | US20060216317 Delivery of polynucleotide agents to the central nervous system |
| 09/28/2006 | US20060216289 GFRalpha3 and its uses |
| 09/28/2006 | US20060216268 Denaturants for sympathomimetic amine salts |
| 09/28/2006 | US20060216244 Delivery of compounds for the treatment of parkinson's through an inhalation route |
| 09/28/2006 | US20060216243 Delivery of Beta-Blockers Through An Inhalation Route |
| 09/28/2006 | US20060216241 Transmucosal absorption through oral mucosa to systemic circulatory system; bioavailability, rapid onset; active ingredient, solvent and low molecular weight hydrocarbon propellant; anxiety, muscle spasms |
| 09/28/2006 | US20060216240 Transmucosal absorption through oral mucosa to systemic circulatory system; bioavailability, rapid onset; active ingredient, solvent and low molecular weight hydrocarbon propellant; sleep disorders |
| 09/28/2006 | DE202005020539U1 Aripiprazol Aripiprazole |
| 09/28/2006 | DE102005014334A1 Preparing hypnotic/sedative, psychopharmacologic drugs/anti-depressive and anxiolytic, for clarifying and strengthening the mind, comprises adding myrrh tincture and wine, mixing sweet wood root juice with mixture and agitating |
| 09/28/2006 | DE102005014141A1 Tablettenförmige Retardzubereitung gegen Schwindel Delayed-release tablets shaped against scams |
| 09/28/2006 | CA2821645A1 A pharmaceutical composition for treating depression and method for preparation thereof |
| 09/28/2006 | CA2602893A1 Use of adnf polypeptides for treating peripheral neurotoxicity |
| 09/28/2006 | CA2602545A1 Phenyl-n-acyl derivatives of amines and amino acids, a process for the preparation thereof, a pharmaceutical composition and the use thereof |
| 09/28/2006 | CA2602445A1 Metabolites for nk-i antagonists for emesis |
| 09/28/2006 | CA2602444A1 Acetylenyl-pyrazolo-pyrimidine derivatives as mglur2 antagonists |
| 09/28/2006 | CA2602194A1 Substituted oxindol derivatives, drugs containing said derivatives and the use thereof |
| 09/28/2006 | CA2602174A1 Substituted oxindole derivatives, medicaments containing the latter and use thereof |
| 09/28/2006 | CA2601795A1 Chewing gum compositions of varenicline |
| 09/28/2006 | CA2601790A1 A pharmaceutical composition for treating depression and method for preparation thereof |
| 09/28/2006 | CA2601766A1 N- [3- (1-amin0-5, 6, 7, 8-tetrahydro-2 , 4, 4b-triazafluoren-9-yl)-phenyl] benzamides as tyrosine/threonine kinase inhibitors, in particular b-raf kinase |
| 09/28/2006 | CA2601523A1 Novel thiophene sulfoximines for treating complement-mediated diseases and conditions |
| 09/28/2006 | CA2601509A1 Alpha7 neuronal nicotinic receptor ligand and antipsychotic compositions |
| 09/28/2006 | CA2601424A1 Substituted oxindole derivatives, medicaments containing the latter and use thereof |
| 09/28/2006 | CA2601000A1 Arylsulfonyl benzofused heterocycles as 5-ht2a antagonists |
| 09/28/2006 | CA2600757A1 Pyrrolidine derivatives as histamine h3 receptor antagonists |
| 09/28/2006 | CA2600478A1 Imidazopyridazine compounds |
| 09/28/2006 | CA2600189A1 2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl-piperidines used as cgrp antagonists |
| 09/27/2006 | EP1705245A1 Neural stem cells |
| 09/27/2006 | EP1705189A1 Feline hepatocyte growth factor |
| 09/27/2006 | EP1705179A1 N-aroyl cyclic amine derivatives as orexin receptor antagonists |
| 09/27/2006 | EP1705169A2 Triphenylalkene derivatives and their use as selective estrogen receptor modulators |
| 09/27/2006 | EP1704862A1 2,5-bis(tetrahydroxybutyl)pyrazines for the treatment of osteoarthritis and rheumatoid arthritis |
| 09/27/2006 | EP1704858A1 Propofol-containing fat emulsion preparation |
| 09/27/2006 | EP1704186A2 Methods and compositions using thalidomide for the treatment and management of central nervous system disorders or diseases |
| 09/27/2006 | EP1704149A1 Triaza-cyclopenta[cd]indene derivatives |
| 09/27/2006 | EP1703918A2 Combination of crf antagonists and 5-ht 1b receptor antagonists |
| 09/27/2006 | EP1703909A1 1-benzoyl-piperazine derivatives as glycine uptake inhibitors for the treatment of psychoses |
| 09/27/2006 | EP1703902A2 Memantine for the treatment of mild and mild-to-moderate alzheimer's disease |
| 09/27/2006 | EP1703898A2 Ziprasidone formulations |
| 09/27/2006 | EP1703896A2 Pharmaceutical compositions comprising midazolam in a high concentration |
| 09/27/2006 | EP1594840B1 Piperidine-benzenesulfonamide derivatives |
| 09/27/2006 | EP1569666B1 Herbal preparation for management of cardiovascular and neurologic disorders |
| 09/27/2006 | EP1565445B1 Process for the preparation of imidazolyl compounds |
| 09/27/2006 | EP1534687B1 2-phenylamino-4-trifluoromethyl-5-(benzyl- or pyridin-4-ylmethyl)carbamoylpyrimidine derivatives as selective cb2 cannabinoid receptor modulators |
| 09/27/2006 | EP1511496B1 Method of treating or preventing immune mediated disorders and pharmaceutical formulation for use therein |
| 09/27/2006 | EP1501826B1 Substituted indoles as alpha-1 agonists |
| 09/27/2006 | EP1458716B1 Bicyclic n-arylamides |
| 09/27/2006 | EP1450792B1 Benzazole derivatives for the treatment of scleroderma |
| 09/27/2006 | EP1404341B1 Active substance combination for medicamentous therapy of nicotine dependency |
| 09/27/2006 | EP1377580B1 Benzenesulfonic acid indol-5-yl esters as antagonists of the 5-ht6 receptor |
| 09/27/2006 | EP1374899B1 Remedies for post-traumatic stress disorder |
| 09/27/2006 | EP1368008B1 Transdermal therapeutic system for the administration of the partial dopamine-d2 agonist aripiprazol |
| 09/27/2006 | EP1303537B1 Ho-1 suppressor as a diagnostic and prognostic test for dementing diseases |
| 09/27/2006 | EP1286967B1 Cyclohexane derivatives and their use as therapeutic agents |
| 09/27/2006 | EP0957921B1 17alpha-dihydroequilenin for preventing neurodegeneration and cognitive dysfunction |
| 09/27/2006 | CN1839134A [1,8]naphthyridin-2-ones and related compounds for the treatment of schizophrenia |
| 09/27/2006 | CN1839124A Succinate and malonate salt of trans-4-(ir,3s)-6-chloro-3-phenylindan-1-yl)-1,2,2-trimethylpiperazine and the use as a medicament |
| 09/27/2006 | CN1838966A Use of human growth hormone in multiple system atrophy |
| 09/27/2006 | CN1838952A Use of [3.2.0] heterocyclic compounds and analogs thereof for the treatment of cancer, inflammation and infectious diseases |
| 09/27/2006 | CN1838950A Methods for treating protein aggregation disorders |
| 09/27/2006 | CN1838946A Pharmaceutical formulations of amyloid inhibiting compounds |
| 09/27/2006 | CN1837207A Pirazino(aza)indole derivatives |
| 09/27/2006 | CN1837195A Pyridine derivatives as nmda-receptor subtype blockers |
| 09/27/2006 | CN1836726A Oral liquid for treating drug addict |
| 09/27/2006 | CN1836713A Medicine for strengtherning brain and tranquilizing mind |
| 09/27/2006 | CN1836710A Granula for cerebrovascular disease and its production method |
| 09/27/2006 | CN1836687A Pharmaceutical composition for treating depression and its making method |
| 09/27/2006 | CN1836684A Silktree albizzia general saponin and its extraction method, pharmaceutical use of the said composition and medicine preparation |
| 09/27/2006 | CN1836682A Gadol drop pills and preparation method thereof |
| 09/27/2006 | CN1836681A Ginseng stem leaves general saponin freeze-drying powder injection and its preparation method |
| 09/27/2006 | CN1836671A Chinese medicinal soft capsule and method for preparing and controlling the quality of Chinese medicinal soft capsule |
| 09/27/2006 | CN1836670A Microsphere injection for treating ophthalmopathy |
| 09/27/2006 | CN1836664A Puerarin self-emulsifying microemulsified composition and its preparation method |
| 09/27/2006 | CN1836661A Use of aconine in medicine manufacture |
| 09/27/2006 | CN1836651A Levogyration sulpiride injection and its preparation method |
| 09/27/2006 | CN1836570A Alcohol-relieving tablet containing kudzu root and spirulina spp. ,and its preparation method |
| 09/27/2006 | CN1276974C Gsk3 polypeptides |
| 09/27/2006 | CN1276970C New strain of lactic acid bacterium and edible compositions, drugs and veterinary products containing it |
| 09/27/2006 | CN1276969C Liquor prepared from traditional medicine and process for its preparation |
| 09/27/2006 | CN1276921C Derivatives of 5-(pyridin-3-yl)-1-azabicyclo[3.2.1] octane, the preparation thereof and the application of same in therapeutics |
| 09/27/2006 | CN1276771C Chinese traditional medicine preparation for treating spasm of eye and facial muscles, and preparing method |
| 09/27/2006 | CN1276769C Chinese medicinal preparation for paraplegia |
| 09/27/2006 | CN1276762C Chinese prepared medicine for treating epilepsy |
| 09/27/2006 | CN1276753C Use of pyridine-2-yl- methylamine derivatives in the treatment of opioid dependence |
| 09/27/2006 | CN1276748C Biofunctional hydroxyapatite coatings and microspheres for in-situ drug encapsulation |
| 09/26/2006 | USRE39308 3,5-dioxa-12-azawurtzitane compound and process of preparing same |
| 09/26/2006 | US7112686 Precipitation from mother liquors by adding bases or acid addition salts to solution of citalopram |
| 09/26/2006 | US7112685 Labeled resiniferatoxin derivatives |
| 09/26/2006 | US7112673 Dibenzo [b,f]azepine intermediates |